 |
ARCA biopharma
ABIO
|
-8.36 |
- |
1052.0 % |
$ 415 M |
USA |
 |
Alpine Immune Sciences
ALPN
|
-6.14 |
- |
- |
$ 2.17 B |
USA |
 |
Arbutus Biopharma Corporation
ABUS
|
-5.18 |
$ 4.67 |
- |
$ 775 M |
Canada |
 |
Aclaris Therapeutics
ACRS
|
-7.59 |
$ 3.36 |
- |
$ 260 M |
USA |
 |
AlloVir
ALVR
|
-0.723 |
- |
4.14 % |
$ 49.1 M |
USA |
 |
Acasti Pharma
ACST
|
-2.73 |
- |
4.01 % |
$ 150 M |
Canada |
 |
Adaptimmune Therapeutics plc
ADAP
|
-14.6 |
- |
-15.15 % |
$ 60.3 M |
Britain |
 |
Ampio Pharmaceuticals
AMPE
|
-0.0776 |
- |
-11.43 % |
$ 502 K |
USA |
 |
Aeglea BioTherapeutics
AGLE
|
-4.6 |
- |
- |
$ 1.01 B |
USA |
 |
Ascendis Pharma A/S
ASND
|
-17.6 |
$ 210.16 |
- |
$ 5 B |
Danmark |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
11.6 |
- |
- |
$ 40.3 B |
USA |
 |
Albireo Pharma
ALBO
|
-5 |
- |
-0.23 % |
$ 916 M |
USA |
 |
AstraZeneca PLC
AZN
|
13.6 |
$ 90.29 |
- |
$ 96.9 B |
Britain |
 |
Ayala Pharmaceuticals
AYLA
|
-0.224 |
- |
- |
$ 7.46 M |
Israel |
 |
Aptorum Group Limited
APM
|
-3.44 |
$ 1.33 |
- |
$ 7.25 M |
China |
 |
Alterity Therapeutics Limited
ATHE
|
-94.9 |
$ 3.42 |
- |
$ 8.23 B |
Australia |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
-3.88 |
- |
-1.52 % |
$ 24.7 M |
USA |
 |
Amphastar Pharmaceuticals
AMPH
|
6.13 |
$ 25.9 |
- |
$ 1.25 B |
USA |
 |
Anika Therapeutics
ANIK
|
-209 |
$ 9.49 |
- |
$ 139 M |
USA |
 |
Brickell Biotech
BBI
|
-2.62 |
- |
-5.38 % |
$ 6.06 M |
USA |
 |
BeiGene, Ltd.
BGNE
|
-1.8 K |
- |
0.49 % |
$ 251 B |
Cayman-islands |
 |
Bellicum Pharmaceuticals
BLCM
|
-0.323 |
- |
-9.72 % |
$ 5.89 M |
USA |
 |
Berkeley Lights
BLI
|
-2.46 |
- |
-7.31 % |
$ 87 M |
USA |
 |
Arena Pharmaceuticals
ARNA
|
-12.5 |
- |
-6.81 % |
$ 3.04 B |
USA |
 |
Biogen
BIIB
|
6.73 |
$ 172.5 |
- |
$ 25.1 B |
USA |
 |
Baudax Bio
BXRX
|
-0.028 |
- |
0.59 % |
$ 63 K |
USA |
 |
Avenue Therapeutics
ATXI
|
-0.0603 |
- |
-52.27 % |
$ 4.45 M |
USA |
 |
Институт стволовых клеток человека
ISKJ
|
-89 |
- |
- |
- |
Russia |
 |
ChromaDex Corporation
CDXC
|
35.6 |
- |
-0.88 % |
$ 598 M |
USA |
 |
Axon Enterprise
AXON
|
97.5 |
$ 581.03 |
- |
$ 44 B |
USA |
 |
Checkpoint Therapeutics
CKPT
|
-5.15 |
- |
- |
$ 169 M |
USA |
 |
Caladrius Biosciences
CLBS
|
-0.185 |
- |
-16.75 % |
$ 25.8 M |
USA |
 |
Clovis Oncology
CLVS
|
-1.18 |
- |
-7.23 % |
$ 13 M |
USA |
 |
BioVie
BIVI
|
-0.128 |
$ 1.51 |
-4.43 % |
$ 2.23 M |
USA |
 |
Cortexyme
CRTX
|
-3.83 |
- |
-1.05 % |
$ 67.1 M |
USA |
 |
Benitec Biopharma
BNTC
|
-23.6 |
$ 12.96 |
1.17 % |
$ 533 M |
USA |
 |
Deciphera Pharmaceuticals
DCPH
|
-8.18 |
- |
- |
$ 2.18 B |
USA |
 |
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
-10.3 |
$ 11.44 |
- |
$ 740 M |
USA |
 |
BioNTech SE
BNTX
|
70.7 |
$ 96.0 |
- |
$ 27.2 B |
Germany |
 |
Eloxx Pharmaceuticals
ELOX
|
-0.193 |
- |
-5.68 % |
$ 8.28 M |
USA |
 |
Can-Fite BioPharma Ltd.
CANF
|
-413 |
$ 0.29 |
-0.31 % |
$ 631 M |
Israel |
 |
Acer Therapeutics
ACER
|
-0.401 |
- |
2.71 % |
$ 14 M |
USA |
 |
Catalyst Biosciences
CBIO
|
1.3 |
$ 15.31 |
- |
$ 1.01 B |
USA |
 |
Enochian Biosciences
ENOB
|
-14.7 |
- |
- |
$ 40.5 M |
USA |
 |
Epizyme
EPZM
|
-0.452 |
- |
- |
$ 249 M |
USA |
 |
Cerus Corporation
CERS
|
26.5 |
$ 2.15 |
- |
$ 397 M |
USA |
 |
Acorda Therapeutics
ACOR
|
-1.2 |
- |
-24.86 % |
$ 820 K |
USA |
 |
Applied Molecular Transport
AMTI
|
-0.236 |
- |
- |
$ 10.1 M |
USA |
 |
Burford Capital Limited
BUR
|
11.6 |
$ 9.14 |
- |
$ 1.5 B |
Britain |